1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Histogen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension Emricasan, Placebo - Cirrhosis, Portal Hypertension | Phase 2 | Completed | Histogen | 263 | 2016-10-17 | 2022-02-11 |
| Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia Hair Stimulating Complex (HSC), Dulbecco's Modified Eagle Medium, DMEM - Androgenetic Alopecia | Phase 1 / Phase 2 | Unknown | Histogen | 56 | 2011-12-01 | 2012-01-18 |
Alopecia (1) · Fibrosis (1) · Hypertension, Portal (1) · Liver Cirrhosis (1) · Non-alcoholic Fatty Liver Disease (1)
Germany (1) · Philippines (1) · Spain (1) · United States (1)
Jeanette M Wetzel (1) · Julieta P. Arambulo, MD (1) · Ruqayyah Abdulrahoof (1) · Samuel Mboggo (1) · Theresa Marie Reyes-Cacas, MD (1)